文献速递艾滋病与性传播感染新发突发、热带与寄生虫病

新冠检测联动HIV检测对HIV流行影响及成本效果

The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该建模研究评估了在美国6个城市将HIV检测与SARS-CoV-2检测联动(自愿退出)对HIV发病率的影响及成本效果。

要点

  • 联动HIV检测可大幅减少HIV新发感染
  • 初期投入较高但长期节省医疗费用
  • 服务中断和风险行为变化影响HIV发病率

核心结论

  • 将HIV检测与SARS-CoV-2检测联动可显著降低HIV发病率并减少直接和间接医疗成本。

研究设计与样本

  • 使用已校准的动态HIV传播模型,在美国6个城市构建三组情景:现状、服务中断与风险行为变化、联动HIV检测。

主要发现

  • 最佳情景下2020-2025年HIV感染减少16.5%,最差情景下增加9.0%。
  • 联动HIV检测(覆盖10%-90%成人)可避免576-7225例新发感染(1.6%-17.2%)。

关键数值与推荐

  • 风险行为减少50%且无服务中断时,HIV感染减少16.5%。
  • 无行为改变且服务可及性减少50%时,HIV感染增加9.0%。
  • 联动检测覆盖10%-90%成人,避免576-7225例感染。

临床怎么用

  • 在SARS-CoV-2检测时同步提供HIV检测(自愿退出)可有效减少HIV传播。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Widespread viral and serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may present a unique opportunity to also test for human immunodeficiency virus (HIV) infection. We estimated the potential impact of adding linked, opt-out HIV testing alongside SARS-CoV-2 testing on the HIV incidence and the cost-effectiveness of this strategy in 6 US cities. METHODS: Using a previously calibrated dynamic HIV transmission model, we constructed 3 sets of scenarios for each city: (1) sustained current levels of HIV-related treatment and prevention services (status quo); (2) temporary disruptions in health services and changes in sexual and injection risk behaviors at discrete levels between 0%-50%; and (3) linked HIV and SARS-CoV-2 testing offered to 10%-90% of the adult population in addition to Scenario 2. We estimated the cumulative number of HIV infections between 2020-2025 and the incremental cost-effectiveness ratios of linked HIV testing over 20 years. RESULTS: In the absence of linked, opt-out HIV testing, we estimated a total of a 16.5% decrease in HIV infections between 2020-2025 in the best-case scenario (50% reduction in risk behaviors and no service disruptions), and a 9.0% increase in the worst-case scenario (no behavioral change and 50% reduction in service access). We estimated that HIV testing (offered at 10%-90% levels) could avert a total of 576-7225 (1.6%-17.2%) new infections. The intervention would require an initial investment of $20.6M-$220.7M across cities; however, the intervention would ultimately result in savings in health-care costs in each city. CONCLUSIONS: A campaign in which HIV testing is linked with SARS-CoV-2 testing could substantially reduce the HIV incidence and reduce direct and indirect health care costs attributable to HIV.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Zang X, Krebs E, Chen S, et al. The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities. Clin Infect Dis. 2021. PMID: 33045723. doi:10.1093/cid/ciaa1547

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。